Testicular function after radiotherapy to inverted 'Y' field for malignant lymphoma.
Asbjornsen G, Molne K, Klepp O, Aakvaag A.
Scand J Haematol. 1976 Aug;17(2):96-100. doi: 10.1111/j.1600-0609.1976.tb01160.x.
Testicular dose and associated risk from inverted-Y field irradiation in patients with Hodgkin's disease.
Mazonakis M, Kokona G, Damilakis J, Varveris H, Gourtsoyiannis N.
Phys Med. 2005 October-December;21(4):137-41. doi: 10.1016/S1120-1797(05)80002-X.
Total lymphoid irradiation for multiple sclerosis.
Devereux CK, Vidaver R, Hafstein MP, Zito G, Troiano R, Dowling PC, Cook SD.
Int J Radiat Oncol Biol Phys. 1988 Jan;14(1):197-203. doi: 10.1016/0360-3016(88)90068-5.
[Immediate hematological toxicity during combination chemotherapy-radiotherapy of Hodgkin's disease].
Peiffert D, Bey P, Lederlin P, Conroy T, Witz F.
Bull Cancer. 1989;76(4):373-82.
Radiotherapy for early infradiaphragmatic Hodgkin's disease: the Australasian experience.
Barton M, Boyages J, Crennan E, Davis S, Fisher RJ, Hook C, Johnson N, Joseph D, Khoo V, Liew KH, Morgan G, O'Brien P, Pendlebury S, Pratt G, Quong G, Roos DE, Thornton D, Trotter G, Walker Q, Wallington M.
Radiother Oncol. 1996 Apr;39(1):1-7. doi: 10.1016/0167-8140(96)01715-x.
Intestinal complications of wide field abdominal irradiation for lymphoma.
Langlois D, Le Bourgeois JP, Leung S, Kuentz M.
Radiother Oncol. 1985 Jun;3(4):293-8. doi: 10.1016/s0167-8140(85)80041-4.
[Somatic radiation risk in large-field irradiation].
Nocken U, Ewen K, Makoski HB.
Strahlentherapie. 1985 Nov;161(11):694-8.
[Radiotherapy treatment of lymphoma].
Juretić A, Zivković M, Samija M, Cović D, Bistrović M, Viculin T, Bagović D, Tomek R.
Lijec Vjesn. 2000 Nov-Dec;122(11-12):283-91.
Transformation in the use of radiation therapy of Hodgkin lymphoma: new concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT).
Yahalom J.
Eur J Haematol Suppl. 2005 Jul;(66):90-7. doi: 10.1111/j.1600-0609.2005.00461.x.
A consensus protocol: Image-improved therapeutic guidelines for limited adult Hodgkin's disease.
Busetto M, Sotti G, Zorat P, Salvagno L, Dal Fior S, Gaion F, Soraru M; Gruppo Veneto Linfomi, Radiotherapy and Medical Oncology sections; Associazione Italiana di Radioterapia Oncologica, Triveneto section.
Tumori. 2004 Nov-Dec;90(6):630-6. doi: 10.1177/030089160409000619.
